TriSalus Life Sciences, Inc. TLSI Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 85.1%-0.5pp | 84.6%-1.5pp | 84%-3.1pp | 84.7%-3.0pp | 85.6%-1.1pp | |
| Operating margin | -62.4%+36.6pp | -59.7%+63.2pp | -77.7%+81.5pp | -86.1%+127pp | -99%+156pp | |
| Net margin | -60.9%+23.8pp | -86.9%+15.2pp | -98.4%+108pp | -86.6%+134pp | -84.7%+208pp | |
| Efficiency | ||||||
| Asset turnover | 0.9×-0.5× | 1.5×+0.3× | 1.3×+0.4× | 1×-0.1× | 1.4×+0.2× | |
| Liquidity | ||||||
| Current ratio | 5.8×+3.6× | 2.8×+0.8× | 3.1×+0.7× | 4.1×+1.8× | 2.1×+1.2× | |
| Leverage | ||||||
| Debt-to-equity | 2.6×— | —— | —— | —— | —— | |
| Per Share | ||||||
| Book value per share | $0.24+120% | -$0.89+12.6% | -$0.62+19.5% | -$0.59+44.1% | -$1.20+22.0% | |
| Valuation | ||||||
| Market capitalization | $279.45M+49.6% | $348.75M+128% | $231.88M+110% | $198.61M+50.5% | $172.66M-24.1% | |
| Price / sales | 6.2×+1.0× | 7.7×+2.5× | 5.8×+1.7× | 5.5×+0.2× | 5.4×-5.0× | |
| Price / book | 22.5×— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are TriSalus Life Sciences, Inc.'s profit margins?
- TriSalus Life Sciences, Inc. (TLSI) runs a 85.1% gross margin and a -62.4% operating margin, with a -60.9% net margin.
- Where do TriSalus Life Sciences, Inc.'s ratios come from?
- Every ratio is computed from TriSalus Life Sciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
